Stock 4552 JCR PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-07-03 am EDT 		5-day change 1st Jan Change
615 JPY -0.65% Intraday chart for JCR Pharmaceuticals Co., Ltd. +1.49% -47.53%
Jul. 01 MEDIPAL Holdings Corporation and JCR Pharmaceuticals Co., Ltd. Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB CI
Jun. 26 JCR Pharmaceuticals Partially Corrects Consolidated Results for Fiscal Year 2024 MT

Evolution of the average Target Price on JCR Pharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

3fd2c3fdec79fb75c7cc1a.9dkjXpQj5KAitf8Yv90zBbOttIw5nFZVhYt5DDknWfs.pawXJP9L3OJO2Ix83YtpS9SAjNVu5AUM5NIbOFxXAamv6UBp3mnS7U_wjA~49096e98032e60c71df78e2eef4c0c8e

Analyst Recommendations on JCR Pharmaceuticals Co., Ltd.

Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 560 Yen From 1,200 Yen, Keeps at Hold MT
Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,200 Yen From 1,400 Yen, Keeps at Hold MT
Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,400 Yen From 1,360 Yen, Keeps at Hold MT
Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,360 Yen From 1,200 Yen, Keeps at Hold MT
Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen MT
Jefferies Adjusts JCR Pharmaceuticals to 1,800 Yen From 2,300 Yen, Keeps at Buy MT
Jefferies Adjusts JCR Pharmaceuticals' Price Target to 2,300 Yen From 3,900 Yen, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
619 JPY
Average target price
851.4 JPY
Spread / Average Target
+37.55%
High Price Target
2,000 JPY
Spread / Highest target
+223.10%
Low Price Target
560 JPY
Spread / Lowest Target
-9.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering JCR Pharmaceuticals Co., Ltd.

Jefferies & Co.
Nomura

Ratings for JCR Pharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4552 Stock
  4. Consensus JCR Pharmaceuticals Co., Ltd.